| Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU plus P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC). | |
| Ou, Y.; Michaelson, M. D.; Sengelov, L.; Saad, F.; Houede, N.; Ostler, P. J.; Stenzl, A.; Daugaard, G.; Jones, R. J.; Laestadius, F. | |
| 2011 | |
| 卷号 | 29 |
| 期号 | 15 |
| 会议录 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0732-183X |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4919353 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Ou, Y.,Michaelson, M. D.,Sengelov, L.,et al. Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU plus P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC).[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论